1. Home
  2. KTB vs SWTX Comparison

KTB vs SWTX Comparison

Compare KTB & SWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KTB
  • SWTX
  • Stock Information
  • Founded
  • KTB 2018
  • SWTX 2017
  • Country
  • KTB United States
  • SWTX United States
  • Employees
  • KTB N/A
  • SWTX N/A
  • Industry
  • KTB Apparel
  • SWTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • KTB Consumer Discretionary
  • SWTX Health Care
  • Exchange
  • KTB Nasdaq
  • SWTX Nasdaq
  • Market Cap
  • KTB 3.0B
  • SWTX 3.5B
  • IPO Year
  • KTB N/A
  • SWTX 2019
  • Fundamental
  • Price
  • KTB $68.56
  • SWTX $46.26
  • Analyst Decision
  • KTB Strong Buy
  • SWTX Buy
  • Analyst Count
  • KTB 5
  • SWTX 7
  • Target Price
  • KTB $84.80
  • SWTX $56.86
  • AVG Volume (30 Days)
  • KTB 658.3K
  • SWTX 8.7M
  • Earning Date
  • KTB 05-06-2025
  • SWTX 05-20-2025
  • Dividend Yield
  • KTB 3.04%
  • SWTX N/A
  • EPS Growth
  • KTB 3.07
  • SWTX N/A
  • EPS
  • KTB 4.07
  • SWTX N/A
  • Revenue
  • KTB $2,599,277,000.00
  • SWTX $191,589,000.00
  • Revenue This Year
  • KTB $2.55
  • SWTX $86.36
  • Revenue Next Year
  • KTB $2.39
  • SWTX $69.02
  • P/E Ratio
  • KTB $16.83
  • SWTX N/A
  • Revenue Growth
  • KTB 1.08
  • SWTX 3417.33
  • 52 Week Low
  • KTB $50.00
  • SWTX $28.21
  • 52 Week High
  • KTB $96.80
  • SWTX $62.00
  • Technical
  • Relative Strength Index (RSI)
  • KTB 65.15
  • SWTX 58.93
  • Support Level
  • KTB $61.18
  • SWTX $46.10
  • Resistance Level
  • KTB $70.08
  • SWTX $46.27
  • Average True Range (ATR)
  • KTB 2.17
  • SWTX 0.90
  • MACD
  • KTB 1.35
  • SWTX 0.58
  • Stochastic Oscillator
  • KTB 88.11
  • SWTX 99.46

About KTB Kontoor Brands Inc.

Kontoor Brands Inc is a lifestyle apparel company. It is engaged in designing, manufacturing, sourcing, marketing, and distribution of its portfolio of brands, including Wrangler and Lee. It manufactures its products in owned and leased facilities and distributes the products through both brick-and-mortar and e-commerce retailers. The Company has two reportable segments: Wrangler and Lee. It generates the majority of its revenue from the Wrangler segment. The company's geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing, and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing prevalent, genetically defined cancers. OGSIVEO, the first commercial product, is a novel, oral, selective gamma-secretase inhibitor. GOMEKLI, the second commercial product, is an oral, small molecule mitogen-activated protein kinase, or MEK, inhibitor.

Share on Social Networks: